loading animation for AJAX calls

Market research reports on:  Pharmaceutical manufacture, cancer, oncology, prevention and treatment, therapeutics, vaccines, clinical studies, drug delivery, immunology, immunotherapy and others.

Let's Connect
277 Reports in Pharmaceuticals

Antifungal Drugs: Technologies and Global Markets

Published - Jun 2020 | Publisher - BCC Publishing| Code - PHM029G

The global market for antifungal drugs should grow from $14.6 billion in 2019 to reach $17.6 billion by 2024, at a compound annual growth rate (CAGR) of 3.8% for the forecast period of 2019-2024.

Health Technology Assessment in Pharma: A Review of Major Decisio...

Published - May 2020 | Publisher - BCC Publishing| Code - PHM228A

The goal of this study is to provide information on the global health technology approval process in North America, Europe and the Asia-Pacific region. The study emphasizes the role of HTA and its function and technology process in the pharmaceutical industry. The report also elaborates on recent HTA approvals and their significance on pricing and reimbursement.

Nanotechnology in Cancer Treatment

Published - Mar 2020 | Publisher - BCC Publishing| Code - PHM222A

According to the National Science Foundation (NSF) the term nano refers to particles, structures, or devices having at least one dimension below 100 nm. Development, manufacturing and sale of these products have spawned a multibillion industry, commonly referred to as the nanotechnology sector. This report gives a market outlook of nanotechnology in cancer treatment and provides information on its most relevant applications. The major trends, issues and recent achievements in nanotechnology-based cancer treatment are also discussed.

Hyperkalemia Market: A BCC Research Perspective

Published - Feb 2020 | Publisher - BCC Publishing| Code - PHM226A

The hyperkalemia market is currently a flourishing market, with a strong drug pipeline and upcoming technologies for the diagnosis of conditions. This report on Hyperkalemia Market highlights market dynamics such as drivers, restraints, opportunities and trends that impact the growth of the market. BCC Research focuses on the comprehensive analysis of the current market for hyperkalemia and the future direction of the market.

Medical Affairs: The Roadmap to 2025

Published - Feb 2020 | Publisher - BCC Publishing| Code - PHM225A

This report on Medical Affairs highlights overall growth due to rapidly changing pharmaceutical and medical device markets by forming new paradigms and employing marketing strategies that increase market share. The research will provide information on leading market competitors, their market share, partnerships, collaborations, mergers and acquisitions between pharmaceutical companies. BCC Research focuses on the importance of medical affairs in communicating and collecting the medical evidence with the organization and external stakeholders.

Bioinks: The Living Foundation of Functional Bioprinting

Published - Feb 2020 | Publisher - BCC Publishing| Code - PHM221A

The goal of this short study is to help companies operating within the life science sector gain valuable insights on bioinks by providing an overview of types, compositions, and applications of bioinks. This report outlines the trends that are expected to contribute to market growth for these materials.

Non-injectable Insulin

Published - Feb 2020 | Publisher - BCC Publishing| Code - PHM224A

This comprehensive report provides an in-depth assessment of the global market for non-injectable insulin. The report's key objective is to analyze areas of opportunities, key developments and the impact of this technology on industry, specifically the pharmaceutical, biotechnology and healthcare sectors. The analysis also reviews the adoption of non-injectable insulin in developed and emerging markets.

Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: ...

Published - Jan 2020 | Publisher - BCC Publishing| Code - PHM223A

In the context of the huge impact of generic drug development and its implication in cost savings, an attempt has been made to analyze various pharmaceutical original products which experience patent expiry and likely to go off patents. The report also covers a section illustrating the case for development and opportunities that lie for manufacturers engaged in the generic or biosimilar business for the key drugs.

ROI in Pharmaceutical R&D: How to Halt the Decline

Published - Jan 2020 | Publisher - BCC Publishing| Code - PHM218A

This report is designed to investigate recent years of performance of pharmaceutical and biopharmaceutical companies with respect to return on investment (ROI) in research and development (R&D), and to discuss ways that companies are trying to improve ROI through 2024. Investigation will include Country/Regional market trends with top areas of return, 2014-2024. This report also looks at which companies are already using artificial intelligence (AI) and machine learning (ML) to successfully compete globally.

Pediatric Medicines: Global Markets

Published - Dec 2019 | Publisher - BCC Publishing| Code - PHM170B

The global pediatric market should grow from $92.6 billion in 2019 to reach $116.6 billion by 2024 at a compound annual growth rate (CAGR) of 4.7% for the period of 2019-2024.

Cannabis Market: Products, Technologies and Applications

Published - Dec 2019 | Publisher - BCC Publishing| Code - PHM217A

The global cannabis market should grow from $25.6 billion in 2019 to $77.6 billion by 2024 at a compound annual growth rate (CAGR) of 24.8% for the period of 2019-2024.

Over-the-Counter (OTC) Drugs and Dietary Supplements: Opportuniti...

Published - Nov 2019 | Publisher - BCC Publishing| Code - PHM219A

This report on Over-the-Counter (OTC) drugs and dietary supplement products market highlights primary healthcare and its various parameters such as the drafting of rules and regulations for OTC drugs and dietary supplements, the number of drugs classified, self-care awareness among consumers and the size of distribution networks, OTC drugs and dietary supplements manufacturers. BCC Research analyzed key categories and regions to determine the present and future OTC drugs and dietary supplement products market status and forecasted market growth.

Significant Drug Launches in 2019: A BCC Research Analysis and In...

Published - Oct 2019 | Publisher - BCC Publishing| Code - PHM220A

This report provides information on significant drug launches in 2019. The study provides an overview of each drug, scientific summaries, pharmacodynamics, pharmacokinetics and clinical trial information, disease backgrounds, analysis of the market, competitors and company profiles of manufacturers. The objective of this study is to present a comprehensive analysis of the current market and its future direction.

Communicable Disease Market: A BCC Research Overview

Published - Aug 2019 | Publisher - BCC Publishing| Code - PHM216A

The global market for communicable disease should grow from $57.7 billion in 2019 to $69.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.8% for the period of 2019-2024.

Continuous Manufacturing in Pharmaceuticals: Implications for the...

Published - Aug 2019 | Publisher - BCC Publishing| Code - PHM214A

This report presents a perspective on the adoption of continuous manufacturing technologies by pharmaceuticals, the role of the FDA and implications for the generics sector.

Neurology Market: A BCC Research Overview

Published - Aug 2019 | Publisher - BCC Publishing| Code - PHM215A

The global market for neurology should grow from $33.3 billion in 2019 to $39.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.5% for the period of 2019-2024.

Interleukin-2, a Tale of Two Halves: To Suppress or Augment Suppr...

Published - Jul 2019 | Publisher - BCC Publishing| Code - PHM212A

The report provides a detailed description of autoimmune responses and possible ways that drug development can augment immune responses so as to improve antitumor activity and reduce off target effect.This report will assess the latest developments in the IL-2 research and development and explore the novel strategies companies are adopting to augment immune response and avoid off target effects in a wide range of conditions including, metastatic melanoma (MM), renal cell carcinoma (RCC), urothelial cancers (US) relapse remitting multiple sclerosis (RRMS), Type 1 diabetes (T1D), as a prophylaxis post-transplant and allergic conditions.What's coming: There are more than 200 studies underway evaluating IL-2 based therapies either as a monotherapy or in combination. The key products and companies that we believe are worth watching in this space are summarized.

Markets at a Glance: Pharmaceuticals

Published - Jun 2019 | Publisher - BCC Publishing| Code - PHM213A

The “Market at a Glance Pharmaceuticals” provides an access to all the market share analysis segments of the best-selling and key pharmaceutical reports of BCC Research. This report is a destination for the competitive landscape in the markets that hold a significant stand in the pharmaceuticals sector. Company profiles for all the notable manufacturers in the global pharmaceutical industry are provided as a part of this report.

Nothing Degrading about Saving Lives: E3 Ligands Recruiting New D...

Published - May 2019 | Publisher - BCC Publishing| Code - PHM192A

Posttranslational modifications hit prime time in the pharma industry. There probably isn’t a medium sized biopharmaceutical that does not have an active program ongoing, and certainly all of the big pharma companies are running multiple programs, and collaborations, for what we might have previously termed “undruggable targets”. Many of these are for highly unmet needs in neurodegeneration. The properties of the structure that forms between a target, a degrader and an E3 ligase, are under intense investigation. Minor changes affect how the drugs work - this can explain how promiscuous target-binding payloads can achieve super selectivity when transformed into a degrader. These minor alterations can also render the molecule complex not only ineffective, but sometimes toxic. However, clinical results are beginning to write a compellingly effective story – the long and winding history of research into the ubiquitin proteasome may well have more blockbusters in store for us. And cures in a once overlooked corner of the cell machinery architecture.

Colorectal Cancer Therapeutics: Global Markets

Published - Apr 2019 | Publisher - BCC Publishing| Code - PHM211A

The global colorectal cancer therapeutics market should reach $18.5 billion by 2023 from $13.7 billion in 2018 at a compound annual growth rate (CAGR) of 6.1% for the period 2018 to 2023.

Drugs of Abuse Testing: Technologies and Global Markets

Published - Apr 2019 | Publisher - BCC Publishing| Code - PHM013H

The global market for drugs of abuse (DOA) testing should grow from $3.5 billion in 2018 to $4.6 billion by 2023 with a compound annual growth rate (CAGR) of 5.6% for the period of 2018-2023.

Laboratory Animal Models, 3D Cultures and Organoids

Published - Apr 2019 | Publisher - BCC Publishing| Code - PHM204A

The global market for laboratory animal models should grow from $5.9 billion in 2018 to $7.8 billion by 2023, increasing at a compound annual growth rate (CAGR) of 5.6% for the period of 2018-2023.

2018 Pharmaceuticals Research Review

Published - Mar 2019 | Publisher - BCC Publishing| Code - PHM099F

2018 Pharmaceuticals Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making.

Laboratory Automation Systems and Processes: Global Markets and T...

Published - Mar 2019 | Publisher - BCC Publishing| Code - PHM201A

The global market for laboratory automation systems and processes should grow from $21.1 billion in 2018 to reach $29.2 billion by 2023 at a compound annual growth rate (CAGR) of 6.8% for the period of 2018-2023.

In Vitro Toxicity Testing: Technologies and Global Markets

Published - Feb 2019 | Publisher - BCC Publishing| Code - PHM017F

The global market for in vitro toxicity testing should grow from $7.4 billion in 2018 to reach $10.4 billion by 2023 at a compound annual growth rate (CAGR) of 7.1% for the period of 2018-2023.

« 2 3 4 5 6 »
4 Upcoming Reports in Pharmaceuticals

Markets for Advanced Wound Management Technologies

Target Date - Jun 2023| Publisher - BCC Publishing | Code - PHM011K| Price - $5,500
Report Includes
  • An up-to-date review and analysis of the global market for advanced wound management (AWM) products and technologies
  • Analyses of the global market trends, with historical market revenue data (sales figures) for 2020 and 2021, estimates for 2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Discussion of industry growth driving factors and major technology issues and challenges affecting the global market for AWM technologies as a basis for projecting demand in the next few years (2023-2028)
  • Estimation of the actual market size and revenue forecast for the global advanced wound management market in USD million values, and corresponding market share analysis based on product type, application, end user, and region
  • Analysis of the market opportunities and future prospects with relate to advanced wound management, applications and business considerations of AWM products and technologies with emphasis on the relevant market forces and macroeconomic factors
  • Review of selected new AWM products in development and emerging technologies, clinical trial applications, and potential markets for future developments
  • Insight into the recent industry structure, competitive aspects of each product segment, increasing investment on R&D activities, market development strategies, and company value share analysis
  • Identification of major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, segmental revenues, and operational integration
  • Detailed company profiles of the major global players

Veterinary Vaccines: Global Markets

Target Date - Jun 2023| Publisher - BCC Publishing | Code - PHM274A| Price - $5,500
Report Includes
  • A comprehensive overview of the current and future global markets for veterinary vaccines
  • Analyses of the global market trends, with historic market revenue data (sales figures) for 2021-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimation of the actual market size and revenue forecast for global veterinary vaccines market in USD millions, and corresponding market share analysis based on the type of vaccine, route of administration, animal type, and region
  • Highlights of upcoming market opportunities and trends driving and restricting growth of global veterinary vaccines market and its sub-segments, and major regions and countries involved in the market developments
  • In-depth information (facts and figures) concerning major market dynamics (DROs), technology advancements, regulatory aspects, and various macroeconomics factors influencing the demand and progress of this market
  • Country specific data and market value analysis for the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Australia, China, India, and Japan etc.
  • Identification of the companies engaged in research and development (R&D) of vaccination and vaccine production, emerging technologies, and a SWOT analysis of leading competitors and their market penetration
  • Detailed company profiles of the major global players

Minimal Residual Disease Testing Market

Target Date - Jul 2023| Publisher - BCC Publishing | Code - PHM275A| Price - $5,500
Report Includes
  • An overview of the global market for minimal residual disease (MRD) testing
  • Analyses of global market trends, with data from 2021, 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028
  • Highlights of the market potential and characterization of MRD market based on technology, application, end-user category, and region
  • Information on technologies used to detect the levels of malignancy that remain after cancer treatment such as flow cytometry, PCR and NGS
  • Detailed description of specific somatic or germline mutations that serve as precise markers to diagnose cancer during ongoing investigations
  • Coverage of major cancers such as leukaemia, lymphoma, and multiple myeloma, and discussion on how MRD level monitoring enables more precise evaluations, thereby identifying the amount of risk or enabling early prevention of future relapse
  • Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis
  • Detailed company profiles of major players in the market

Global Acute myeloid leukemia (AML) Treatment Market Forecast and Trends

Target Date - Jul 2023| Publisher - BCC Publishing | Code - PHM276A| Price - $5,500
Report Includes
  • An overview of the global market for acute myeloid leukaemia (AML) treatment
  • Analyses of global market trends, with data from 2021, 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028
  • Highlights of the market potential and characterization of AML market based on treatment type, route of administration type, end-users, distribution channel, region
  • Coverage of various risk factors associated with AML, such as exposure to radiation or chemicals, genetic disorders, and weakened immune system
  • Description of major treatment options for AML such as, chemotherapy, targeted therapy, and stem cell transplantation
  • Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis
  • Detailed company profiles of major players in the market
 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM